Detalles de la búsqueda
1.
Implementing mainstream genetic counseling within the area-wide network of the German Consortium Hereditary Breast and Ovarian Cancer (GC-HBOC): Satisfaction of primary care providers with the provided state-of-the-art training by the Cologne Center.
J Genet Couns
; 33(1): 206-215, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38351721
2.
The effect of denosumab on disseminated tumor cells (DTCs) of breast cancer patients with neoadjuvant treatment: a GeparX translational substudy.
Breast Cancer Res
; 25(1): 32, 2023 03 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36978142
3.
Psychological distress and decision-making factors for prophylactic bilateral mastectomy in cancer-unaffected BRCA1/2 pathogenic variant carriers.
Psychooncology
; 32(4): 640-648, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36774644
4.
Ovarian cancer onset across different BRCA mutation types: a view to a more tailored approach for BRCA mutated patients.
Int J Gynecol Cancer
; 33(2): 257-262, 2023 02 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36581488
5.
Effectiveness of evidence-based decision aids for women with pathogenic BRCA1 or BRCA2 variants in the german health care context: results from a randomized controlled trial.
BMC Med Inform Decis Mak
; 23(1): 223, 2023 10 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37845719
6.
Genetic clinicians' confidence in BOADICEA comprehensive breast cancer risk estimates and counselees' psychosocial outcomes: A prospective study.
Clin Genet
; 102(1): 30-39, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35508697
7.
Influence of aging and gadolinium exposure on T1, T2, and T2*-relaxation in healthy women with an increased risk of breast cancer with and without prior exposure to gadoterate meglumine at 3.0-T brain MR imaging.
Eur Radiol
; 32(1): 331-345, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34218287
8.
Medical knowledge and information needs among women with pathogenic variants in moderate-risk genes for hereditary breast cancer attending genetic counseling at an academic hospital in Germany-A qualitative approach.
J Genet Couns
; 31(3): 698-712, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34837291
9.
Psychological factors and the uptake of preventative measures in BRCA1/2 pathogenic variant carriers: results of a prospective cohort study.
Hered Cancer Clin Pract
; 20(1): 38, 2022 Dec 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-36536421
10.
Nurse-led decision coaching by specialized nurses for healthy BRCA1/2 gene mutation carriers - adaptation and pilot testing of a curriculum for nurses: a qualitative study.
BMC Nurs
; 21(1): 42, 2022 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35139834
11.
Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials.
Lancet Oncol
; 22(8): 1151-1161, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34252375
12.
Physical activity and Mediterranean diet as potential modulators of osteoprotegerin and soluble RANKL in gBRCA1/2 mutation carriers: results of the lifestyle intervention pilot study LIBRE-1.
Breast Cancer Res Treat
; 190(3): 463-475, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34570303
13.
Precursor fractions of neurotensin and enkephalin might point to molecular mechanisms of cancer risk modulation during a lifestyle-intervention in germline BRCA1/2 gene mutation carriers.
Breast Cancer Res Treat
; 186(3): 741-752, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33543354
14.
Clinical outcome in patients with primary epithelial ovarian cancer and germline BRCA1/2-mutation - real life data.
Gynecol Oncol
; 163(3): 569-577, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34565600
15.
Risk-Adjusted Prevention. Perspectives on the Governance of Entitlements to Benefits in the Case of Genetic (Breast Cancer) Risks.
Recent Results Cancer Res
; 218: 47-66, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34019162
16.
Cost-Effectiveness of Targeted Genetic Testing for Breast and Ovarian Cancer: A Systematic Review.
Value Health
; 24(2): 303-312, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33518037
17.
Development of decision aids for female BRCA1 and BRCA2 mutation carriers in Germany to support preference-sensitive decision-making.
BMC Med Inform Decis Mak
; 21(1): 180, 2021 06 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34090422
18.
Modern day screening for Lynch syndrome in endometrial cancer: the KEM experience.
Arch Gynecol Obstet
; 304(4): 975-984, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33710393
19.
Breast cancer risk in BRCA1/2 mutation carriers and noncarriers under prospective intensified surveillance.
Int J Cancer
; 146(4): 999-1009, 2020 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31081934
20.
Cancer surveillance and distress among adult pathogenic TP53 germline variant carriers in Germany: A multicenter feasibility and acceptance survey.
Cancer
; 126(17): 4032-4041, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32557628